The pharmaceutical industry is growing worldwide, with United States and China being the top 2 countries in the overall pharmaceutical market. As of 2021, these countries held a share of 40% and 12% in the global pharmaceutical market.
For instance, the production value of processed food products in Japan amounted to be around USD170 billion (22.6 trillion yens).
Increasing Demand of Pharmaceutical Industry
According to the European Federation of Pharmaceutical Industries and Associations, in 2021, North America accounted for 49.1% of world pharmaceutical sales compared with 23.4% for Europe. Moreover, during 2016–2021, the Brazilian, Chinese, and Indian markets grew by 11.7%, 6.7%, and 11.8%, respectively, compared to average market growth of 5.8% for the top 5 European Union markets and 5.6% for the United States market.
Rising Usage in Food and Beverages Sector
Plant-based Microcrystalline Cellulose Gaining Prominence in bakery applications. With the aid of acid hydrolysis of cellulose, plant-based microcrystalline cellulose is produced from fruits, plants, and vegetables. Manufacturers have the pure form of microcrystalline cellulose, which is physiologically inert and may be used in bakery and confectionery in more significant quantities. They are making more Microcrystalline Cellulose found at, which is secure, sugar- and gluten-free, and suitable for dairy products. Microcrystalline cellulose is also used in the production of dietary supplements, snacks, burger patties, among others.
Growing Use in Paints & Coatings
Microcrystalline cellulose is gaining popularity as a functional fiber polymer which can be used as an emulsion stabilizer. Various companies operating in the market are widely using microcrystalline cellulose in paints & coatings applications and also taking initiatives to spread awareness regarding the same.
Market Segmentation
Global Microcrystalline Cellulose Market is segmented based on
Market Players
DuPont, Asahi Kasei Corporation, JRS Pharma, Roquette Frères, Mingtai Chemical Co. Ltd., Chemfield Cellulose, Accent Microcell Pvt. Ltd., JRS Pharma, Pharmatrans-Sanaq AG and DFE Pharma are some of the key players operating in the global microcrystalline cellulose market.
Recent Developments
Various companies operating in the market are following strategies such as product launches, mergers & acquisitions, collaborations & partnerships, among others in order to stay competitive and have an edge over other players operating in the market.
·
Attribute | Details |
Base Year | 2022 |
Historic Data | 2018 – 2021 |
Estimated Year | 2023 |
Forecast Period | 2024 – 2028 |
Quantitative Units | Revenue in USD Million, Volume in metric tons, and CAGR for 2018-2022 and 2023-2028 |
Report coverage | Revenue forecast, Volume Forecast, company share, competitive landscape, growth factors, and trends |
Segments covered | · By Type · By Application |
Regional scope | North America, Europe, Asia Pacific, Middle East & Africa |
Country scope | United States, Canada, Mexico, France, Germany, United Kingdom, Italy, Spain, China, India, Japan, South Korea, Australia, Brazil, Argentina, Colombia, Saudi Arabia, UAE, South Africa |
Key companies profiled | DuPont de Nemours, Inc., Asahi Kasei Corporation, JRS Pharma, Roquette Frères SA, Mingtai Chemical Co. Ltd., Chemfield Cellulose Private Limited, Accent Microcell Pvt. Ltd., Pharmatrans-Sanaq AG |
Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |